Two Sigma Advisers
TENX icon

Two Sigma Advisers’s Tenax Therapeutics TENX Stock Holding History

Two Sigma Advisers’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,178
Closed -$161K – 1923
2025
Q4 		$161K Buy
+13,178
New +$115K ﹤0.01% 2158
2021
Q1 		– Sell
-14
Closed -$41K – 2719
2020
Q4 		$41K Sell
14
-50
-78% -$92K ﹤0.01% 2333
2020
Q3 		$156K Buy
64
+38
+146% +$81.1K ﹤0.01% 2207
2020
Q2 		$37K Buy
+26
New +$38.2K ﹤0.01% 2438

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers's TENX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Tenax Therapeutics (TENX) in Q1 2026, closing a stake of 13,178 shares — an estimated $161K sold.

Two Sigma Advisers first reported a position in TENX in Q2 2020 and held it in 4 quarters. The position peaked at $161K in Q4 2025. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Two Sigma Advisers reported no remaining Tenax Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 13,178 Tenax Therapeutics shares in Q1 2026, an estimated $161K.
  • Two Sigma Advisers first reported a position in Tenax Therapeutics in Q2 2020 and held it in 4 quarters.
  • Two Sigma Advisers's Tenax Therapeutics position peaked at $161K in Q4 2025.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.